The Pulmonary hypertension program provides comprehensive assessment and management for all types of pulmonary hypertension. Extensive evaluation includes state-of-the-art invasive vasodilator testing.
Our specialized team provides 24-hour care for outpatient and urgent inpatient support. This dedicated team of professionals is committed to providing exceptional care and in-depth assistance for all aspects of this unique disease process.
Treatment options range from FDA-approved oral, inhaled, injectable and continuous IV therapies to involvement in research protocols from the latest clinical trials.
We provide assistance with reimbursement and insurance issues, and help connect patients with appropriate medication assistance programs, when needed.
Minneapolis Heart Institute providers are able to care for patients in every stage of pulmonary hypertension - from assisting with risk assessments to surgical treatment when necessary.
Durand Burns, MD, FACC
Barry Cabuay, MD, FACC
Director, Pulmonary Hypertension Program
Eric R Fenstad, MD, MSc, FACC
Casey Lawler, MD, FACC
Peter Zimbwa, MD, PhD
Emily Anderson, RN